Holley Schmidt | Assistant Controller |
Kevin McNamara | President and Chief Executive Officer |
Dave Williams | Executive Vice President and Chief Financial Officer |
Nick Westfall | President and Chief Executive Officer-VITAS Healthcare Corporation Subsidiary |
Joanna Gajuk | Bank of America |
Ben Hendrix | RBC Capital Markets |
Mike Wiederhorn | Oppenheimer |
Good morning.
Our conference call this morning will review the financial results for the Fourth Quarter of 2022 ended December 31, 2022.
Before we begin, let me remind you that the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call.
During the course of this call, the company will make various remarks concerning management’s expectations, predictions, plans and prospects that constitute forward-looking statements. Actual results may differ materially from these projected by these forward-looking statements as a result of a variety of factors, including those identified in the company’s news release of February 23 and in various other filings with the SEC.